Coomes EA; Al?Shamsi HO; Meyers BM; Alhazzani W; Alhuraiji A; Chemaly RF; Almuhanna M; Wolff RA; Ibrahim NK; Chua ML; Hotte SJ; Elfiki T; Curigliano G; Eng C; Grothey A; Xie C
Oncologist 2020[Aug]; 25 (8): e1252-3 PMID32378772show ga
This letter to the editor remarks on additional considerations for the management of febrile neutropenia during the COVID?19 pandemic, in response to the letter by Boutayeb et al.